NALTREXONE Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description An organic heteropentacyclic compound that is 4,5-epoxymorphinan-6-one substituted by a cyclopropylmethyl group at position 17 and hydroxy groups at positions 3 and 14. A mu-opioid receptor antagonist, it is used to treat alcohol dependence. (Chemical Entities of Biological Interest Ontology, CHEBI_7465)
External Link https://dgidb.org/results?searchType=drug&searchTerms=NALTREXONE
Similar Terms
Downloads & Tools

Genes

11 interacting proteins for the NALTREXONE drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
AKR1C4 aldo-keto reductase family 1, member C4 4.812
ADH1C alcohol dehydrogenase 1C (class I), gamma polypeptide 1.604
ANKK1 ankyrin repeat and kinase domain containing 1 1.37486
ALDH2 aldehyde dehydrogenase 2 family (mitochondrial) 0.9624
DBH dopamine beta-hydroxylase (dopamine beta-monooxygenase) 0.874909
SIGMAR1 sigma non-opioid intracellular receptor 1 0.178222
OPRD1 opioid receptor, delta 1 0.167374
COMT catechol-O-methyltransferase 0.150375
OPRK1 opioid receptor, kappa 1 0.146931
OPRM1 opioid receptor, mu 1 0.103484
DRD2 dopamine receptor D2 0.0433513